Close

Jump to:

  • Navigation
  • Content
  • Footer
Aguulp hero image

Aguulp

Follow

Aguulp for health. Aguulp for happiness. Aguulp for you.

102%
 - 
Funded 25 Nov 2020
£300,003 target
£307,913 from 184 investors
More
Less

Business overview

Location Mersham, United Kingdom
Social media
Website www.aguulp.com
Sectors Healthcare Digital B2C
Company number 11782769
Incorporation date 23 Jan 2019
More
Less

Investment summary

Type Equity
Valuation (pre-money) £2M
Equity offered 13.23%
Tax relief

EIS

More
Less

Business highlights

  • Liquid liposomal technology that delivers 98% nutrient absorption
  • A Gut Test that measures Short-Chain Fatty Acids
  • 27% increase in overall gut health across 2-month clinical trial
  • Celebrity co-founders with 6m combined social media followers
More
Less

Key features

  • Secondary Market
  • Nominee investment min. £17.50 +
  • Idea
  • Team
  • Updates
  • Investors 184
  • Discussion
  • Documents

Idea

Please note that whilst the campaign is labelled as EIS eligible the Company has £40,000 remaining of its SEIS limit. Any tax relief is dependent on personal circumstances and may be subject to change in the future.

Introduction

Vitamins in pill form have an absorption rate as low as 5% and take 30 minutes for your stomach to break down, a process during which your stomach acid is eating the nutrients before you get a chance to.

Aguulp is different. We make easily absorbed supplements that absorb up to 98% of our nutrients.

We use liquid formulas that assimilate in the body at a fraction of the time it takes for a pill to break down.

NutriProtect, our groundbreaking liposomal technology, shields nutrients from corrosive stomach acid, which destroys a majority of nutrients before they reach the small intestine for absorption. This ensures that our key vitamins and minerals get where they need to go in order to provide you with optimal benefits.

Our debut products include Aguulp for Gut, which improves digestion and common gut ailments like bloating and IBS through increased microbiome diversity; Aguulp for Brain, which promotes stronger focus, clarity, memory recall and reduces brain fog; and Aguulp for Immunity, which fortifies the body’s natural defenses. Our Gut Test is the first in a line of at-home diagnostic testing that provides results which help educate both dietary and lifestyle choices. With repeat testing it also allows our customers to monitor their improvement as people continue their journey with Aguulp.

Our monthly subscription service ensures the products are always on hand for optimally functioning guts, brains, immunity and whatever else customers may need along the way.

Substantial accomplishments to date

- Assembled a high-level team that includes popular personalities in music and television and mental-health activism with a vested interest in supplements that improve health and mood after their well-documented journeys with mental health, alongside experienced entrepreneurs and investors who together have raised more than $30bn in capital to date.

- Partnered with Nutrivitality, a GMP- and ISO-accredited lab with over 25 years of experience working with the nutritional supplement industry.

- Outstanding clinical trial results. In just two months, 27% of participants increased their overall gut health and 16% achieved ideal gut health.

- Created unique liquid formulas that deliver up to 98% nutrient absorption using groundbreaking science.

- Created a modern Gut test that measures Short-Chain Fatty Acids, not DNA.

- Clinically proven gut and brain formulas ready to take to market and formulas for immunity, sleep and hangovers in late-stage R&D.

Monetisation strategy

The core product in our subscription based model is our hero Gut and Brain formula at £70 per month. Our Immunity formula retails at £30.

From launch we will be selling individual Gut & Brain products - both retailing at £40 - and Immunity, which retails at £30. We are also launching a unique gut test that measures Short Chain Fatty Acids - retailing at £80.

We intend to release one new product each quarter, starting with the Aguulp for Sleep formula, quickly followed by Aguulp for Recovery.

Our founding partners Stephen Manderson (aka Professor Green) and Channel 4's Jason Fox will connect with their nearly six million followers across social media channels and advertise beyond their own audiences via the many media channels they have access to. There is keen interest already from broad-sheet and tabloid press; from popular lifestyle publications; and for TV appearances across the many mainstream chat and panel shows Stephen and Jason have long-established relationships with.

The digestive health products market size is projected to reach $57.54bn by 2025. The supplements segment is anticipated to reach $7.08bn by 2025.

Google Trends analysis (June 2017) demonstrated that “gut health” and “bloating” are amongst the fastest growing search terms when it comes to managing health, with "best foods for gut health" up 350% over the last 5 years in the U.S.

Use of proceeds

Total Marketing - 55.6% (breakdown below).

Content: Animation: 1.2%.
Content: Design for social and paid assets: 2.9%.
Overall brand direction and packaging design: 4%.
Social: Organic strategy and community building: 3%.
Paid Social: Strategist and audience targeting: 3%.
Paid Media: Budget for ad placement (Facebook, Google): 39.4%.
Launch Party: 0.6%.
Gift boxes + Product for pre-launch seeding: 1%.
Presence at Events & Conferences: 1.6%.
Customer services: 3.6%.
Affiliates and sponsorships (Blogs, Podcasts, newsletters): 3.6%.

Total Staff - 42.2% (breakdown below).

CEO: 11.4%.
Communications Manager: 6%.
Sales & Marketing Manager: 6%.
Social Media Assistant: 3.6%.

Investor Perks

1) Invest £500 receive a free trial pack of HERO products, GUT, BRAIN and IMMUNITY, plus T-Shirt and membership of the the aguulper club, to receive product trials, testers kits and innovative testers.

2) Invest £1,000 the above, plus a Christmas gift hamper with out December launch products, SLEEP and RECOVERY

3) Invest £5,000 a years subscription to Gut and Brain and annual test of your gut before and after kit, plus an invite to a celebrity influencer party in 2021 for 2.

Please note that any discounts, rewards and/or offers listed by a company in its campaign are subject to the terms and conditions applied by that company and listed above. It is the company’s responsibility to honour such discounts, rewards and/or offers and Seedrs does not take any responsibility for them.

Open an account to get access to the team members of Aguulp

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This campaign for Aguulp has been approved by Seedrs Limited (trading as Republic Europe) ("Republic Europe", "us" or "we"), as of 1 October 2020 as a financial promotion. Republic Europe is authorised and regulated by the Financial Conduct Authority with firm reference number 550317. In approving this campaign, Republic Europe has concluded that the information, taken as a whole, is "fair, clear and not misleading." This means that for factual statements we have reviewed evidence of their accuracy, and that for aspirational statements we believe they are phrased appropriately in light of their speculative nature. You should note that in the case of factual statements, the evidence we review is provided by the business, and we do not audit it, which means that we may not be able to identify forged or altered evidence. You should further note that in the case of aspirational statements, the nature of the type of businesses presented on the Republic Europe platform is such that they are likely to have high ambitions, and we may approve statements that convey those ambitions even where we do not believe, or we do not have a view on whether it is likely, that they will be fully realised. The pre-money valuation and investment sought in the campaign are those set by the business: they are not reviewed or established by us, and the valuation is not an independent view of what the business is worth. Given the nature and type of businesses presented on the Republic Europe platform, it is possible that the business has very little cash remaining prior to receiving this investment, and the investment sought may be necessary for the business's on-going existence.

Republic Europe does not make investment recommendations to you. No communications from Republic Europe, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £2,018,590

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

The investee business is responsible for setting its own valuation, it has not been prescribed by Seedrs.

Pitch type

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Nominee investment

This shows if you are able to choose, when making an investment, that you be represented by, and your shareholding be managed by, the Nominee investment.

Find out more

Custodian

If you invest in this Campaign, Seedrs will act as Custodian rather than provide our standard nominee service. This is due to the fact that the business is not directly involved in the share sale and Seedrs will not benefit from any rights under a shareholder agreement. As a result, Seedrs will handle administrative tasks as we do normally, but you will not have information or voting rights, updates from the business, preemption on future fundraising, or ongoing support about business trading activity.

Learn more about Custodian here

Secondary market

This shows if the business has opted-in or opted-out of allowing its shares to be bought and sold on the secondary market.

Find out more

Direct investment

This is an option to invest and hold shares 'directly' in the company (rather than via the Nominee investment). This option is only available to those investing over the threshold amount, which is determined by the fundraising company.

If you choose to hold your shares directly, you will be responsible for any contractual or administrative arrangements with the company you are investing in.

Find out more

Payment options

We are not able to accept card payments for investments into this sector. You can pay for your investment by creating a bank transfer, using funds in your investment account or create a Pay by Bank payment. Your investment will only be completed once the funds have reached our account.

Business Involvement

This Campaign offers shares for sale in business that is not directly involved in this Campaign or the sale. As a result, the Campaign and post-investment experience, including investor rights, will differ from a business-led campaign on Seedrs. Most notably, the business will not engage with investors in the discussion forums both during and after the sale or provide any updates to investors.

Learn more here

Payment options

We are not able to accept Pay by Bank payments for investments into this sector. You can pay for your investment with a card payment, by creating a bank transfer or by using funds in your investment account. Your investment will only be completed once the funds have reached our account.

Drawdowns

This campaign offers the ability to pay for an investment by drawdowns.

Security Token

A security token is a digital asset that represents ownership or other rights. It is a digital form of traditional investments. In the future, you may be able to trade your investment through compatible exchanges.

Warning

You are following a link outside of europe.republic.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel